Funding Rounds
LabGenius

LabGenius Series B (2024, $44M)

LabGenius

Biopharmaceutical company developing protein therapeutics with a machine learning-driven evolution engine.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $44.47M

Investors